Allison Waters1, Karen Jennings2, Emma Fitzpatrick3, Suzie Coughlan3, Eleanor J Molloy2, Cillian F De Gascun4, William W Hall3, Susan J Knowles2. 1. National Virus Reference Laboratory (NVRL), University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: allison.waters@ucd.ie. 2. National Maternity Hospital (NMH), Holles Street, Dublin 2, Ireland. 3. National Virus Reference Laboratory (NVRL), University College Dublin, Belfield, Dublin 4, Ireland. 4. Frimley Park Hospital, Surrey, United Kingdom.
Abstract
BACKGROUND: Congenital cytomegalovirus (cCMV) causes serious intrauterine infection and is the leading cause of sensorineural hearing loss. In the absence of routine screening, asymptomatic infections, which constitute approximately 90% of all cCMV cases, remain undiagnosed; however many clinical abnormalities manifest later in childhood. OBJECTIVES: The aims of the present study were to determine, for the first time, the incidence of cCMV infection in a large maternity hospital in Dublin city and the optimal sampling method for neonatal screening. STUDY DESIGN: A pilot screening study of asymptomatic infants born was conducted over a 12-month period. Mothers were consented and neonates screened for evidence of CMV infection (n=1044). Urine or saliva was tested for the presence of CMV DNA and reactive results were confirmed with follow-up testing and clinical evaluation. RESULTS: cCMV incidence in the asymptomatic neonates screened was 0.19%. An overall cCMV incidence was extrapolated based on the total number of live-births and data from those infants routinely screened for cCMV during the study period, and estimated as 0.23%. Neonatal urine collection proved prohibitive to mass screening. However, testing of saliva for CMV DNA was rapid, sensitive and suitable for screening. Furthermore, in a low prevalence population, pooling of patient samples proved effective and cost-efficient. CONCLUSIONS: The present study concluded that there is a significant burden of undiagnosed cCMV infection in Ireland. The introduction of neonatal CMV DNA testing of saliva is viable, and could be considered as part of the national newborn screening programme, following a cost-benefit analysis.
BACKGROUND: Congenital cytomegalovirus (cCMV) causes serious intrauterine infection and is the leading cause of sensorineural hearing loss. In the absence of routine screening, asymptomatic infections, which constitute approximately 90% of all cCMV cases, remain undiagnosed; however many clinical abnormalities manifest later in childhood. OBJECTIVES: The aims of the present study were to determine, for the first time, the incidence of cCMV infection in a large maternity hospital in Dublin city and the optimal sampling method for neonatal screening. STUDY DESIGN: A pilot screening study of asymptomatic infants born was conducted over a 12-month period. Mothers were consented and neonates screened for evidence of CMV infection (n=1044). Urine or saliva was tested for the presence of CMV DNA and reactive results were confirmed with follow-up testing and clinical evaluation. RESULTS: cCMV incidence in the asymptomatic neonates screened was 0.19%. An overall cCMV incidence was extrapolated based on the total number of live-births and data from those infants routinely screened for cCMV during the study period, and estimated as 0.23%. Neonatal urine collection proved prohibitive to mass screening. However, testing of saliva for CMV DNA was rapid, sensitive and suitable for screening. Furthermore, in a low prevalence population, pooling of patient samples proved effective and cost-efficient. CONCLUSIONS: The present study concluded that there is a significant burden of undiagnosed cCMV infection in Ireland. The introduction of neonatal CMV DNA testing of saliva is viable, and could be considered as part of the national newborn screening programme, following a cost-benefit analysis.
Authors: Shannon A Ross; Amina Ahmed; April L Palmer; Marian G Michaels; Pablo J Sánchez; Audra Stewart; David I Bernstein; Kristina Feja; Zdenek Novak; Karen B Fowler; Suresh B Boppana Journal: Pediatr Infect Dis J Date: 2015-08 Impact factor: 2.129
Authors: Valeria Rubinacci; Mara Fumagalli; Giulia Meraviglia; Laura Gianolio; Anna Sala; Marta Stracuzzi; Anna Dighera; Gian Vincenzo Zuccotti; Vania Giacomet Journal: Children (Basel) Date: 2022-05-03
Authors: Paddy Ssentongo; Christine Hehnly; Patricia Birungi; Mikayla A Roach; Jada Spady; Claudio Fronterre; Ming Wang; Laura E Murray-Kolb; Laila Al-Shaar; Vernon M Chinchilli; James R Broach; Jessica E Ericson; Steven J Schiff Journal: JAMA Netw Open Date: 2021-08-02
Authors: Jaythoon Hassan; Derek O'Neill; Bahman Honari; Cillian De Gascun; Jeff Connell; Mary Keogan; David Hickey Journal: Medicine (Baltimore) Date: 2016-02 Impact factor: 1.817